These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7771545)

  • 1. Platelet-activating factor increases vascular resistance in rat hindquarters by thromboxane A2.
    Rizzo A; Taylor AE; Townsley MI; Logsdon P; Khimenko PL; Fletcher JR
    Am J Physiol; 1995 May; 268(5 Pt 2):H1954-8. PubMed ID: 7771545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
    László F; Whittle BJ; Moncada S
    Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor-induced coronary constriction in the isolated perfused guinea pig heart and antagonistic effects of the PAF antagonist WEB 2086.
    Felix SB; Steger A; Baumann G; Busch R; Ochsenfeld G; Berdel WE
    J Lipid Mediat; 1990; 2(1):9-20. PubMed ID: 2133268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.
    Filep JG; Fournier A; Földes-Filep E
    Br J Pharmacol; 1994 Jul; 112(3):963-71. PubMed ID: 7921626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
    Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
    Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activating factor-induced microvascular permeability increases in the cat hindlimb.
    Lu Z; Wolf MB
    Circ Shock; 1993 Sep; 41(1):8-18. PubMed ID: 8403248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAF effects on eicosanoid release in neonatal rat cardiomyocytes.
    Becker K; Heinroth-Hoffmann I; Giessler C; Pönicke K; Brodde OE
    Prostaglandins Leukot Essent Fatty Acids; 1995 Sep; 53(3):197-200. PubMed ID: 7480082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of thromboxane A2 and platelet activating factor in early haemodynamic response to lipopolysaccharide in rats.
    Bocheński J; Chłopicki S; Gryglewski RJ
    J Physiol Pharmacol; 1999 Jun; 50(2):287-97. PubMed ID: 10424723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
    Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
    Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of eicosanoids in PAF-induced increases of the vascular permeability in rat airways.
    Sirois MG; Plante GE; Braquet P; Sirois P
    Br J Pharmacol; 1990 Dec; 101(4):896-900. PubMed ID: 2085713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of prostanoids with the platelet activating factors.
    Mentz P; Mentz G; Giessler C; Mest HJ
    Prostaglandins Leukot Essent Fatty Acids; 1992 Sep; 47(1):13-6. PubMed ID: 1279731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of platelet activating factor and thromboxane A2 in the renal response to unilateral ureteral obstruction.
    Felsen D; Loo MH; Marion DN; Vaughan ED
    J Urol; 1990 Jul; 144(1):141-5. PubMed ID: 2141654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of thromboxane and leukotrienes to PAF-induced impairment of lung function in the rat.
    Uhlig S; Wollin L; Wendel A
    J Appl Physiol (1985); 1994 Jul; 77(1):262-9. PubMed ID: 7961243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1 enhances vascular permeability in conscious rats: role of thromboxane A2.
    Sirois MG; Filep JG; Rousseau A; Fournier A; Plante GE; Sirois P
    Eur J Pharmacol; 1992 Apr; 214(2-3):119-25. PubMed ID: 1516634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of platelet-activating factor and thromboxane A2 on isolated perfused guinea pig liver.
    Ruan Z; Shibamoto T; Shimo T; Koizumi T; Tsuchida H; Kurata Y; Ogura T; Kubo K
    Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):73-85. PubMed ID: 15165033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of platelet-activating factor and thromboxane A2 in radical production during ischemia and reperfusion of the rat brain.
    Matsuo Y; Kihara T; Ikeda M; Ninomiya M; Onodera H; Kogure K
    Brain Res; 1996 Feb; 709(2):296-302. PubMed ID: 8833766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of thromboxane A2 in airway microvascular leakage induced by inhaled platelet-activating factor.
    Tokuyama K; Lötvall JO; Morikawa A; Barnes PJ; Chung KF
    J Appl Physiol (1985); 1991 Nov; 71(5):1729-34. PubMed ID: 1837014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor increases lung vascular permeability to protein.
    Burhop KE; Garcia JG; Selig WM; Lo SK; van der Zee H; Kaplan JE; Malik AB
    J Appl Physiol (1985); 1986 Dec; 61(6):2210-7. PubMed ID: 3804927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
    Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR
    Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.